Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Mar 30:11:100.
doi: 10.1186/1475-2875-11-100.

Molecular markers in plasmodium falciparum linked to resistance to anti-malarial drugs in samples imported from Africa over an eight-year period (2002-2010): impact of the introduction of artemisinin combination therapy

Aranzazu Amor  1 , Carlos Toro, Amalia Fernández-Martínez, Margarita Baquero, Agustín Benito, Pedro Berzosa
Affiliations

Molecular markers in plasmodium falciparum linked to resistance to anti-malarial drugs in samples imported from Africa over an eight-year period (2002-2010): impact of the introduction of artemisinin combination therapy

Aranzazu Amor et al. Malar J. .

Abstract

Background: Drug resistance is a major problem to control Plasmodium falciparum infection in endemic countries. During last decade, African countries have changed first-line treatment to artemisinin-based combinations therapy (ACT); sulphadoxine-pyrimethamine (SP) is recommended for Intermittent Preventive Therapy (IPT). Molecular markers related to P falciparum resistance were analysed for the period of transition from SP to ACT, in isolates imported from Africa.

Methods: A first group of samples was taken in the period between June 2002 and June 2006 (n = 113); a second group in the period between November 2008 and August 2010 (n = 46). Several alleles were analysed by nested PCR-RFLP: 51, 59, 108, 164, in the pfdhfr gene; 436, 437, 540, 581, in the pfdhps gene; 86, 1246, in the pfmdr1 gene and 76, in the pfcrt gene. The prevalence of alleles in the groups was compared with the chi-squared or Fisher's exact tests.

Results: The pfdhfr N51I, C59R and S108N were over to 90% in the two groups; all samples had the I164. In the pfdhps, 437 G and 581 G, increased up to 80% and 10.9% (p = 0.024), respectively in the second group. The 540 G decreases (24% to 16.%) and the 436A disappears at the end of the follow-up (p = 0.004) in the second group. The 76I-pfcrt stayed over 95% in the two groups. Prevalence of 86Y-pfmdr1 decreased over eight years.

Conclusions: Pharmacological pressure affects the resistance strains prevalence. As for SP, the disappearance of 436A and the decrease in 540 G suggest that these mutations are not fixed. On the other hand, studies carried out after ACT introduction show there was a selection of strains carrying the SNPs N86Y, D1246Y in pfmdr1. In this work, the prevalence of pfmdr1- D1246Y is increasing, perhaps as a result of selective pressure by ACT. Continued surveillance is essential to monitor the effectiveness of treatments.

PubMed Disclaimer

Figures

Figure 1
Figure 1
African countries of origin of samples.
See this image and copyright information in PMC

References

    1. Steketee R, Voltaire F, Hay SI, Alonso PL, Atta HY, Bassat Q, Bakyaita N, Clark JP, Doumbo OK, Drakeley C, Eckert EL, Eisele T, Gausi K, Guinovart C, Hayes N, Kilian A, Lama M, Meek S, Miller J, Nahlen B, Otten M, Ratcliffe A, López MH, Slutsker L, Greenwood B, Tanner M. A research agenda for malaria eradication: monitoring, evaluation, and surveillance. PLoS Med. 2011;8:e1000400. - PMC - PubMed
    1. Malisa AL, Pearce RJ, Abdulla S, Mshinda H, Kachur PS, Bloland P, Roper C. Drug coverage in treatment of malaria and the consequences for resistance evolution - evidence from the use of sulphadoxine/pyrimethamine. Malar J. 2010;9:190. doi: 10.1186/1475-2875-9-190. - DOI - PMC - PubMed
    1. Mita T, Tanabe K, Kita K. Spread and evolution of Plasmodium falciparu drug resistance. Parasitol Int. 2009;58:201–209. doi: 10.1016/j.parint.2009.04.004. - DOI - PubMed
    1. Lehane AM, van Schalkwyk DA, Valderramos SG, Fidock DA, Kirk K. Differential drug efflux or accumulation does not explain variation in the chloroquine response of Plasmodium falciparu strains expressing the same isoform of mutant PfCRT. Antimicrob Agents Chemother. 2011;55:2310–2318. doi: 10.1128/AAC.01167-10. - DOI - PMC - PubMed
    1. Sá JM, Twu O, Hayton K, Reyes S, Fay MP, Ringwald P, Wellems TE. Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine. Proc Natl Acad Sci USA. 2009;106:18883–18889. doi: 10.1073/pnas.0911317106. - DOI - PMC - PubMed

Publication types

MeSH terms